|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 39/395 | (2006.01) |
| A61P 35/00 | (2006.01) | ||
| C07K 16/18 | (2006.01) | ||
| C07K 16/28 | (2006.01) |
| (11) | Number of the document | 3310386 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16815196.7 |
| Date of filing the European patent application | 2016-06-22 | |
| (97) | Date of publication of the European application | 2018-04-25 |
| (45) | Date of publication and mention of the grant of the patent | 2021-07-21 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2016/038702 |
| Date | 2016-06-22 |
| (87) | Number | WO 2016/209921 |
| Date | 2016-12-29 |
| (30) | Number | Date | Country code |
| 201562182699 P | 2015-06-22 | US | |
| 201662319036 P | 2016-04-06 | US |
| (72) |
DOSHI, Parul , US
LOKHORST, Henk, M. , NL
MUTIS, Tuna , NL
|
| (73) |
Janssen Biotech, Inc. ,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
| (54) | COMBINATION THERAPIES FOR HEME MALIGNANCIES WITH ANTI-CD38 ANTIBODIES AND SURVIVIN INHIBITORS |
| COMBINATION THERAPIES FOR HEME MALIGNANCIES WITH ANTI-CD38 ANTIBODIES AND SURVIVIN INHIBITORS |